Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: Relevance of lipophilicity and affinity for ACE

American Journal of Hypertension

Volumn 23, Issue 11, 2010, Pages 1179-1182

  Ruzicka, Marcel ^a,b   Coletta, Elizabeth ^a   White, Roselyn ^a   Davies, Ross ^a   Haddad, Haissam ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

ACE inhibitors; blood pressure; cardiac aldosterone; cardiac angiotensin II; chronic heart failure; hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LISINOPRIL; LOOP DIURETIC AGENT; PERINDOPRIL; QUINAPRIL;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA ROOT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HUMAN; LIPOPHILICITY; MALE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE BLIND PROCEDURE;

ADULT; AGED; ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTA, THORACIC; CORONARY SINUS; FEMALE; HEART CATHETERIZATION; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPERTENSION; LIPIDS; LISINOPRIL; MALE; MIDDLE AGED; PERINDOPRIL; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; RENIN-ANGIOTENSIN SYSTEM; TETRAHYDROISOQUINOLINES; YOUNG ADULT;

EID: 77958087130     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.148     Document Type: Article

References (13)

1. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, Harada E, Nakayama M, Nakamura S, Ito T, Shimasaki Y, Saito Y, Nakao K. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103:72-77.
2. Serneri GG, Boddi M, Cecioni I, Vanni S, Coppo M, Papa ML, Bandinelli B, Bertolozzi I, Polidori G, Toscano T, Maccherini M, Modesti PA. Cardiac angiotensin formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res 2001; 88:961-968.
3. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Horie H, Sugimoto Y, Kinoshita M. Spironolactone nhibits the transcardiac extraction of aldosterone in patients with congestive heart failure J Am Coll Cardiol 2000; 36:838-844.
4. Mizuno Y, Yasue H, Yoshimura M, Fujii H, Yamamoto N, Nakayama M, Harada E, Sakamoto T, Nakamura S, Ito T, Shimasaki Y, Ogawa H, Saito Y, Nakao K. Effects of perindopril on aldosterone production in the failing human heart. Am J Cardiol 2002; 89:1197-1200.
5. Saino A, Pomidossi G, Perondi R, Morganti A, Turolo L, Mancia G. Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease. Circulation 2000; 101:2277-2283.
6. Ondetti MA. Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity. Circulation 1988; 77:I74-I78.
7. Thind GS. Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics. Cardiovasc Drugs Ther 1990; 4: 199-206.
8. Johnston CI, Fabris B, Yamada H, Mendelsohn FA, Cubela R, Sivell D, Jackson B. Comparative studies of tissue inhibition by angiotensin converting enzyme nhibitors J Hypertens Suppl 1989; 7:S11-S16. (Pubitemid 19269331)
9. Kinoshita A, Urata H, Bumpus FM, Husain A. Measurement of angiotensin converting enzyme inhibition in the heart. Circ Res 1993; 73:51-60.
10. Fabris B, Chen BZ, Pupic V, Perich R, Johnston CI. Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue. J Cardiovasc Pharmacol 1990; 15 Suppl 2:S6-13.
11. Ruzicka M, Leenen FH. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy Circulation 1995; 91:16-19.
12. Ruzicka M, Skarda V, Leenen FH. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. Circulation 1995; 92:3568-3573.
13. Lal A, Veinot JP, Leenen FH. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Cardiovasc Res 2004; 64:437-447.